CONMED Corporation is a medical technology company that designs, manufactures, and distributes devices and equipment for surgical procedures. The company's products serve surgeons and other healthcare professionals in orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. With approximately 3,900 employees, CONMED operates from three primary manufacturing locations and is headquartered in Largo, Florida. The company focuses on delivering high-quality, technologically advanced solutions supported by strong customer service.

CONMED generates revenue primarily from the sale of its orthopedic surgery and general surgery product lines. In 2025, orthopedic surgery accounted for 42% of net sales and general surgery for 58%, yielding total net sales of $1.37 billion. A significant portion of revenue comes from single use products, representing about 78% of orthopedic sales and 92% of general surgery sales, which provide a recurring revenue stream. The company also earns income from related services such as fluid management and visualization systems.

The company operates through the following segments:.

• Orthopedic Surgery: This segment designs, manufactures, and distributes products for sports medicine injuries in the knee, hip, shoulder, and lower extremities, including BioBrace®, TruShot® with Y-Knot® All-In-One Soft Tissue Fixation System, Y-Knot® All-Suture Anchors, Argo™ Knotless Suture Anchors, powered resection instruments, fluid management and visualization systems, and arthroplasty, biologic, fracture, and fixation systems for foot and ankle surgery; it also offers the Hall® surgical brand of battery operated power tools for bone surgery across multiple specialties.

• General Surgery: This segment provides a wide range of products for advanced surgical and endoscopic procedures, featuring the AirSeal® insufflation system, smoke removal devices from the Buffalo Filter acquisition, an extensive energy line of electrosurgical generators and accessories, endomechanical instruments such as tissue retrieval bags, trocars, graspers, scissors, and dissectors, and therapeutic and diagnostic devices for gastroenterology and pulmonology including dilation, hemostasis, biliary management, and patient monitoring products.

CONMED holds a competitive position in the global medical device market by offering a broad portfolio that addresses diverse surgical needs, allowing it to compete with larger firms such as Smith & Nephew plc, Arthrex, Inc., Stryker Corporation, Johnson & Johnson (including DePuy Mitek and DePuy Synthes), Zimmer Biomet, Inc., Medtronic plc, Olympus Corporation, and Boston Scientific Corporation. Its advantages include a strong focus on single use products, close collaboration with surgeons for product development, extensive worldwide distribution through subsidiaries in over 30 countries, and a reputation for quality and regulatory compliance.

The company sells to a diversified customer base that includes hospitals, surgery centers, ambulatory care facilities, group purchasing organizations, integrated delivery networks, and federal agencies such as the Veterans Administration; no single customer accounted for more than 10% of net sales in 2025. CONMED’s products are distributed in over 100 countries through a mix of direct sales subsidiaries and independent distributors.